Franchise Global To Acquire German Pharmaceutical And Medical Cannabis Products Distributor, Strengthening Its Position In The German Pharmaceutical And Medical Cannabis Market
Acquiring Company
Franchise Global
Acquired Company
Medical Cannabis Products
Description
Franchise Global Health Inc. ("Franchise Global" or the "Company") (TSX‐V: FGH; FRA: WV4A) is pleased to announce that it has entered into a letter of intent (the "LOI") dated effective May 6, 2022, outlining the general terms and conditions pursuant to which it has agreed to acquire a leading German pharmaceutical distributor (the "Target Company"). Management of Franchise Global expects that the acquisition, if completed, will strengthen the Company's end-to-end pharmaceutical, medical cannabis operations and infrastructure in Germany, a key market for the Company.
Quick answer
Franchise Global is acquiring Medical Cannabis Products and Pharmaceutical Distributor, announced May 16, 2022.
- How much did Franchise Global pay for Medical Cannabis Products?
- The deal value was not disclosed.
- What does Franchise Global do?
- Franchise Global, through its subsidiaries, is a multi-national operator in the medical cannabis and pharmaceutical industries, with principal operations in Germany and with operations, assets, strategic partnerships..
Source: Fundz verified event record.
Other recent acquisitions in Community And Lifestyle and Food And Beverage
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Hikma Completes Acquisition Of Custopharm (April 21, 2022)
- Bristol Myers Squibb To Acquire Turning Point Therapeutics, A Leading Precision Oncology Company (June 3, 2022)
- Halozyme Completes Antares Pharma Acquisition (May 24, 2022)
- Aprea Therapeutics Announces Acquisition Of Atrin Pharmaceuticals Inc. And Reports First Quarter 2022 Financial Results (May 16, 2022)
- Pfizer To Acquire Biohaven Pharmaceuticals (May 10, 2022)
- Halozyme To Acquire Antares Pharma To Create A Specialty Product And Drug Delivery Leader (April 13, 2022)
Who to call at Franchise Global, and when
When Franchise Global changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Franchise Global raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Franchise Global, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Franchise Global. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Franchise Global makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Medical Cannabis Products?
Medical Cannabis Products was acquired by Franchise Global. The deal was reported on May 16, 2022. Franchise Global is privately held and operates in Biotechnology.
When did Franchise Global acquire Medical Cannabis Products?
Franchise Global's acquisition of Medical Cannabis Products was reported on May 16, 2022. Franchise Global Health Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Medical Cannabis Products do?
Medical Cannabis Products is the company acquired in this transaction. It is privately held.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.